坎德萨坦辅助抑郁症试验-CADET:双盲,随机,安慰剂控制的双极抑郁症和严重抑郁症试验的研究方案
Melanie M Ashton1, Chun Hui J Park1, Brisa S Fernandes1
1Deakin University, IMPACT-The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong.
Journal of clinical psychopharmacology
|March 13, 2026
概括
在CADET试验中,正在研究candesartan作为治疗双相情感和重度抑郁症的新疗法. 这项研究将确定candesartan是否有效减少抑郁症状,以及它是否有效.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 在双相情感障碍和严重抑郁症中,抗治疗抑郁症呈现出大量未满足的医疗需求.
- 新兴的研究将氨酸- ангиотензин系统与与抑郁症相关的细胞应激反应联系起来.
- 坎德沙坦是一种血管激素II型1受体抑制剂,可以通过减轻神经炎症和氧化应激来提供一种新的抗抑郁药物策略.
研究的目的:
- 评估坎德沙坦作为双极性抑郁症和重度抑郁症的辅助治疗的疗效.
- 探索氨酸- ангиотензин系统在这些情绪障碍的病理生理学和治疗中的作用.
- 评估坎德沙坦抗抑郁药的抗抑郁作用是否通过氨酸 - 血管素系统进行介导.
主要方法:
- 两项并行的16周双盲随机化安慰剂受控试验 (CADET-BD和CADET-UD) 涉及240名成年参与者.
- 主要结局:从基线到第16周,抑郁症状的变化 (蒙特哥马利·阿斯伯格抑郁评分表).
- 二次结果:评估抑郁,躁狂,焦虑,生活质量,成本效益,功能,物质使用和认知.
主要成果:
- 由于试验正在进行中,研究结果尚未公布.
结论:
- 在CADET试验将确定candesartan在减少单极和双极抑郁症的抑郁症状的疗效.
- 坎德沙坦是一种负担得起,易于使用和耐受良好的药物.
- 如果证明有效,甘地沙坦可以迅速被纳入临床实践,作为一种新的抑郁症辅助疗法.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.9K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.9K
Antidepressant Drugs: Overview
1.9K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.9K
Drug Therapy
364
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
364
Dose-Response Relationship: Potency and Efficacy
7.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
7.1K
Electroconvulsive Therapy
1.7K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.7K


